SHULAMIT RON-BIGGER

Track

Insider profile

Performance

Overall performance
Performance over holding periods
30 days 90 days 120 days
Average return 13% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
3 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
SHULAMIT RON-BIGGER's trades of Aktis Oncology Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Sale
Price
415.21
Quantity 36,526 -10.5%
Value US$4,811,426
Transaction date
Sale
Price
492.27
Quantity 14,506 -8.6%
Value US$1,252,335
Transaction date
Sale
Price
258.72
Quantity 48,818 +23.9%
Value US$4,220,806
Transaction date
Proposed sale
Price
27.75
Quantity 50,000
Value US$1,387,560
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-07-10 2026-07-08
S Sale
36,526 -10.5%
415.21
US$4,811,426 		36,526 -10.5% 415.21 US$4,811,426
2026-07-10 2026-07-08
S Sale
14,506 -8.6%
492.27
US$1,252,335 		14,506 -8.6% 492.27 US$1,252,335
2026-07-10 2026-07-08
S Sale
48,818 +23.9%
258.72
US$4,220,806 		48,818 +23.9% 258.72 US$4,220,806
2026-07-08 2026-07-08
PrS Proposed sale
50,000
27.75
US$1,387,560 		50,000 27.75 US$1,387,560